During the past decade, CHR Verviers conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHR Verviers" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "AZ-VUB" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Galera Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHR Verviers" #1 collaborator was "Anticancerfund" with 1 trials as a collaborator, "Belgium and Luxembourg Gynaecological Oncology Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Israel Society of Gynecologic Oncology" with 1 trials as a collaborator and "Kom Op Tegen Kanker" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "CHR Verviers" are "Breast Cancer" (2 trials), "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Anemia" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "CHR Verviers" in a lesser frequency.

Most popular intervention types in "CHR Verviers" are "Drug" (10 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Archival Tumor Tissue Sample" (1 trials), "Bevacizumab" (1 trials), "CHEMOTHERAPY then HORMONOTHERAPY" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHR Verviers" are 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "CHR Verviers". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in CHR Verviers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHR Verviers, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".